Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2019 Pilot

NCT04723342 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Childhood Acute Lymphoblastic Leukemia

Interventions

DRUG: Blinatumomab

Sponsor

Federal Research Institute of Pediatric Hematology, Oncology and Immunology